PharVision Advisers’s Seadrill SDRL Stock Holding History

PharVision Advisers’s Portfolio SDRL Stock Details SDRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,831	Closed	-$271K	–	549
2025 Q4	$271K	Buy	+7,831	New	+$244K	0.14%	339

Other funds holding SDRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

GRA

Goehring & Rozencwajg Associates New York $1.74B AUM 48.6% 1-Year Est. Return

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PharVision Advisers's SDRL Position: Q1 2026 in Review

PharVision Advisers sold out of Seadrill (SDRL) in Q1 2026, closing a stake of 7,831 shares — an estimated $271K sold.

PharVision Advisers first reported a position in SDRL in Q4 2025 and held it in 1 quarter. The position peaked at $271K in Q4 2025. 245 funds tracked by Wall St. Rank hold SDRL as of Q1 2026.

PharVision Advisers reported no remaining Seadrill position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 7,831 Seadrill shares in Q1 2026, an estimated $271K.
PharVision Advisers first reported a position in Seadrill in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Seadrill position peaked at $271K in Q4 2025.
245 funds tracked by Wall St. Rank held Seadrill as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.